Skip to main content

Fecal Incontinence clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

    Sorry, not currently recruiting here

    This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphincter injury. Half of the participants will receive iltamiocel (injections with cells) and the other half will receive placebo.

    Orange, California and other locations

Last updated: